Context Therapeutics Q4 EPS $(0.14) Misses $(0.10) Estimate

Benzinga Newsdesk www.benzinga.com Negative 97.5%

Neg 97.5% Neu 0% Pos 0%

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.10) by 34.62 percent.